- Evidation Health, a San Mateo, Calif.-based digital health company, closed a $153m Series E growth funding
- The round co-led by Omers Growth Equity and Kaiser Permanente Group Trust with participation from existing investors McKesson Ventures and B Capital Group
- The company intends to use the funds to accelerate the expansion of virtual health programs on the platform
- The company’s platform used by millions of individuals, generating data with speed and scale
- To date, Evidation has conducted more than 100 real-world studies across therapeutic areas
- In 2020, the company reached the milestone of more than 1 million individuals participating in research and health programs and expects to surpass 2 million later this year
